Novel aspects of the endocrinology of the menstrual cycle

Slides:



Advertisements
Similar presentations
MEN: feedback loop.
Advertisements

THE MENSTRUAL CYCLE 1 Resources
GnRH agonist and GnRH antagonist protocols in ovarian stimulation: differential regulation pathway of aromatase expression in human granulosa cells  Mohamad.
Improved monitoring of ovarian stimulation using 3D transvaginal ultrasound plus automated volume count  Maximilian Murtinger, Alexander Aburumieh, Paul.
Physiology of the menstrual cycle
Reproductive Anatomy of Female
Modified natural cycle IVF and mild IVF: a 10 year Swedish experience
Recap questions chapter 8b
Kay Neumann, Georg Griesinger  Reproductive BioMedicine Online 
Diet and endometriosis risk: A literature review
Blastocyst-stage versus cleavage-stage embryo transfer in women with high oestradiol concentrations: randomized controlled trial  Eman A. Elgindy, Ahmed.
Live births after management of severe OHSS by GnRH antagonist administration in the luteal phase  TG Lainas, IA Sfontouris, IZ Zorzovilis, GK Petsas,
Fresh and cryopreserved ovary transplantation and resting follicle recruitment  Sherman Silber, Jorge Pineda, Kathleen Lenahan, Michael DeRosa, Jeffrey.
J. C. Castillo, M. Dolz, E. Bienvenido, L. Abad, E. M. Casañ, F
J. C. Castillo, M. Dolz, E. Bienvenido, L. Abad, E. M. Casañ, F
Double GnRH-antagonist dose before HCG administration may prevent OHSS in oocyte-donor cycles: a pilot study  Yannis Prapas, Ioannis Panagiotidis, Ioannis.
Mid-luteal progesterone concentrations are associated with live birth rates during ovulation induction  J.-C. Arce, A. Balen, P. Platteau, G. Pettersson,
Effect of HCG-day serum progesterone and oestradiol concentrations on pregnancy outcomes in GnRH agonist cycles  Ze Wu, Rong Li, Yanping Ma, Bo Deng,
Single-dose GnRH agonist administration in the luteal phase of GnRH antagonist cycles: a prospective randomized study  A.Z. Isik, G.S. Caglar, E. Sozen,
Pharmacokinetics and follicular dynamics of corifollitropin alfa versus recombinant FSH during ovarian stimulation for IVF  Bart C.J.M. Fauser, Michael.
Preovulatory progesterone concentration associates significantly to follicle number and LH concentration but not to pregnancy rate  Claus Yding Andersen,
Withdrawal of GnRH agonist decreases oestradiol and VEGF concentrations in high responders  Li-Jun Ding, Bin Wang, Xiao-Yue Shen, Gui-Jun Yan, Ning-Yuan.
No association between endogenous LH and pregnancy in a GnRH antagonist protocol: part II, recombinant FSH  George Griesinger, Daniel B. Shapiro, Efstratios.
Anti-Müllerian hormone for the assessment of ovarian response in GnRH-antagonist- treated oocyte donors  Nikolaos P. Polyzos, Dominic Stoop, Christophe.
Oestradiol valerate pretreatment in GnRH-antagonist cycles: a randomized controlled trial  Christophe Blockeel, Sara Engels, Michel De Vos, Patrick Haentjens,
High serum oestradiol concentrations in IVF cycles increase the risk of pregnancy complications related to abnormal placentation  Jacob Farhi, Avi Ben.
Double stimulations during the follicular and luteal phases of poor responders in IVF/ICSI programmes (Shanghai protocol)  Yanping Kuang, Qiuju Chen,
HDlive ultrasound images in assisted reproduction treatment
New strategies of ovarian stimulation based on the concept of ovarian follicular waves: From conventional to random and double stimulation  Giovanna Sighinolfi,
C. Motteram, B. Vollenhoven, N. Hope, T. Osianlis, L.J. Rombauts 
Short follicular phase of stimulation following corifollitropin alfa or daily recombinant FSH treatment does not compromise clinical outcome: a retrospective.
Menstrual cycle and Ovulation
Sherman Silber  Reproductive BioMedicine Online 
Impact of high serum progesterone during the late follicular phase on IVF outcome  Charlotte Sonigo, Géraldine Dray, Clémence Roche, Isabelle Cédrin-Durnerin,
Why are reproductive cancers more common in nulliparous women?
Failure of the GnRH antagonist ganirelix to block the positive feedback effect of exogenous estrogen in normal women  Ioannis E. Messinis, M.D., Ph.D.,
Hakan Cakmak, M. D. , Audra Katz, R. N. , Marcelle I. Cedars, M. D
Sarah McCredie, William Ledger, Christos A. Venetis 
Effect of N-acetyl-cysteine after ovarian drilling in clomiphene citrate-resistant PCOS women: a pilot study  A. Nasr  Reproductive BioMedicine Online 
Ongoing pregnancies from early retrieval of prematurely developing antral follicles after DHEA supplementation  Murat Sönmezer, Aylin Pelin Çil, Kutluk.
M. Dieterich, M. Bolz, T. Reimer, S. Costagliola, B. Gerber 
Steroid profiles by liquid chromatography-mass spectrometry of matched serum and single dominant ovarian follicular fluid from women undergoing IVF  Kirsty.
Cross-border reproductive care: a review of the literature
Sequential use of letrozole and gonadotrophin in women with poor ovarian reserve: a randomized controlled trial  Vivian Chi Yan Lee, Carina Chi Wai Chan,
Jyotsna Pundir, Sesh Kamal Sunkara, Tarek El-Toukhy, Yacoub Khalaf 
Ronit Machtinger, Raoul Orvieto  Reproductive BioMedicine Online 
Follicular flushing in natural cycle IVF does not affect the luteal phase – a prospective controlled study  M. von Wolff, A. Kohl Schwartz, P. Stute,
Male age negatively influences clinical pregnancy rate in women younger than 40 years undergoing donor insemination cycles  Su-Ann Koh, Katherine Sanders,
A retrospective analysis of ovarian stimulation with letrozole in women undergoing artificial insemination by donor  X.J. Sun, L. Jiang, L.C. Ji, R. Nie,
Mid-follicular LH supplementation in women aged 35–39 years undergoing ICSI cycles: a randomized controlled study  R Matorras, B Prieto, A Exposito, R.
Follicular and endocrine profiles associated with different GnRH-antagonist regimens: a randomized controlled trial  Juan Antonio García-Velasco, Sanja.
A unique biological in-vivo model to evaluate follicular development during in-vitro maturation treatment  S.E. Elizur, W.Y. Son, H. Clarke, D. Morris,
V Isachenko, E Isachenko, R Kreienberg, M Woriedh, JM Weiss 
Intra-cycle variation of the uterine cavity indentation assessed with three-dimensional ultrasound in natural and stimulated cycles  Sotirios H. Saravelos,
Double GnRH-antagonist dose before HCG administration may prevent OHSS in oocyte-donor cycles: a pilot study  Yannis Prapas, Ioannis Panagiotidis, Ioannis.
LH concentrations do not correlate with pregnancy in rFSH/GnRH antagonist cycles  Kevin Doody, Paul Devroey, Keith Gordon, Han Witjes, Bernadette Mannaerts 
Mohamed A. Aboulghar, Heba Marie, Yahia M. Amin, Mona M
Anna Pia Ferraretti, Paul Devroey, M. Cristina Magli, Luca Gianaroli 
GnRH antagonist pre-treatment: one centre's experience for IVF–ICSI cycle scheduling  Veronique Viardot-Foucault, Sadhana Nadarajah, Weng Kit Lye, Heng.
Variation in antral follicle counts at different times in the menstrual cycle: does it matter?  Dimitrios Mavrelos, Ali Al Chami, Vikram Talaulikar, Elizabeth.
Serum inhibin A concentration in women with polycystic ovarian syndrome and the correlation to ethnicity, androgens and insulin resistance  Shimon Segal,
Does exogenous LH in ovarian stimulation improve assisted reproduction success? An appraisal of the literature  Micah J. Hill, Gary Levy, Eric D. Levens 
C Almeida, M Sousa, A Barros  Reproductive BioMedicine Online 
Cryopreserved embryo transfer: adjacent or non-adjacent to failed fresh long GnRH- agonist protocol IVF cycle  Alexander Volodarsky-Perel, Talia Eldar-Geva,
Ovarian reserve screening before contraception?
Live birth following early follicular phase oocyte collection and vitrified-warmed embryo transfer 8 days later  Safak Hatırnaz, Ebru Hatırnaz, Baris.
Nat. Rev. Nephrol. doi: /nrneph
C. Yding Andersen, K. Vilbour Andersen  Reproductive BioMedicine Online 
Fertility in cancer patients after cryopreservation of one ovary
Use of progestins to inhibit spontaneous ovulation during ovarian stimulation: the beginning of a new era?  Antonio La Marca, Martina Capuzzo  Reproductive.
Presentation transcript:

Novel aspects of the endocrinology of the menstrual cycle Ioannis E. Messinis, Christina I. Messini, Konstantinos Dafopoulos  Reproductive BioMedicine Online  Volume 28, Issue 6, Pages 714-722 (June 2014) DOI: 10.1016/j.rbmo.2014.02.003 Copyright © 2014 Reproductive Healthcare Ltd. Terms and Conditions

Figure 1 Changes in the strength of the negative feedback mechanism during the normal menstrual cycle. The ovarian mediators are in the early follicular phase oestradiol and inhibin B, in the rest of the follicular phase oestradiol plus progesterone and in the luteal phase oestradiol, progesterone and inhibin A. The LH surge is the result of the positive feedback effect of oestradiol facilitated by progesterone. Reproductive BioMedicine Online 2014 28, 714-722DOI: (10.1016/j.rbmo.2014.02.003) Copyright © 2014 Reproductive Healthcare Ltd. Terms and Conditions

Figure 2 A hypothesis of gonadotrophin surge-attenuating factor (GnSAF) bioactivity during the follicular phase of the normal menstrual cycle: changes in the LH response to gonadotrophin-releasing hormone (GnRH) from the early to late follicular phase. Oestradiol concentration increases as the dominant follicle becomes ovulatory, while that of GnSAF declines. These changes in GnSAF activity facilitate the sensitizing effect of oestradiol on the pituitary response to GnRH leading to the massive discharge of LH during the LH surge. Reproductive BioMedicine Online 2014 28, 714-722DOI: (10.1016/j.rbmo.2014.02.003) Copyright © 2014 Reproductive Healthcare Ltd. Terms and Conditions

Figure 3 The positive feedback mechanism. Factors involved in the control of the onset, amplitude and termination of the endogenous LH surge in the normal menstrual cycle. Oestradiol in high concentration is the main trigger of the onset, facilitated by progesterone on one hand and the withdrawal of the antagonistic action of gonadotrophin surge-attenuating factor (GnSAF) on the other hand (Figure 2). The amplitude of the LH surge is the result of the interaction between the amplifying effect of the increasing concentration of progesterone and the attenuating effect of GnSAF. Finally, the termination of the LH surge is controlled by the ovary via rising progesterone, while the role of oestradiol is unclear. Reproductive BioMedicine Online 2014 28, 714-722DOI: (10.1016/j.rbmo.2014.02.003) Copyright © 2014 Reproductive Healthcare Ltd. Terms and Conditions